TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area

The aim of this study is to examine the impact of tumor necrosis factor inhibitors (TNFI) on nontuberculous mycobacterium (NTM) infection in rheumatoid arthritis (RA) patients in a mycobacterium tuberculosis (MTB) endemic area. We selected 1089 TNFI-treated RA patients and 4356 untreated RA patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong Won, Kim, Yun Jin, Sung, Yoon-Kyoung, Chung, Sung Jun, Yeo, Yoomi, Park, Tai Sun, Lee, Hyun, Moon, Ji-Yong, Kim, Sang-Heon, Kim, Tae-Hyung, Yoon, Ho Joo, Sohn, Jang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901670/
https://www.ncbi.nlm.nih.gov/pubmed/35256729
http://dx.doi.org/10.1038/s41598-022-07968-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901670/
https://www.ncbi.nlm.nih.gov/pubmed/35256729
http://dx.doi.org/10.1038/s41598-022-07968-w

Ejemplares similares